![]() |
市場調查報告書
商品編碼
2127952
止鼾設備的市場規模、佔有率、成長和全球產業分析,區域趨勢,以及 2026 年至 2034 年的預測。Anti-snoring Devices Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
全球止鼾設備市場預計到2025年將達到10.6億美元,從2026年的11.4億美元成長到2032年的20億美元,預測期內複合年成長率(CAGR)為7.36%。北美市場將引領全球市場,預計到2025年將佔37.88%的市場佔有率,這主要得益於睡眠障礙的高發生率、人們對阻塞型睡眠呼吸中止症(OSA)的認知不斷提高以及先進止鼾產品的廣泛應用。
止鼾器是一種非侵入性解決方案,旨在透過防止氣道阻塞和減少組織振動,在睡眠期間保持氣道暢通。典型產品包括下顎前突矯正器(MAD)、舌繫帶固定器(TRD)、鼻擴張器、下顎帶和持續性正壓呼吸器(CPAP)配件。越來越多的習慣性打鼾或輕度至中度阻塞型睡眠呼吸中止症患者開始使用這些產品。消費者對價格實惠、非手術治療的偏好日益成長,以及非處方(OTC)止鼾器的普及,持續推動全球市場的成長。
市場促進因素
睡眠障礙盛行率的不斷上升是推動止鼾設備市場成長的最強勁動力之一。近期全球估計數據顯示,約有9.36億30至69歲的成年人患有輕度至重度阻塞型睡眠呼吸中止症,使得有效治療方法的需求量龐大。未經治療的打鼾和睡眠呼吸中止症與心血管疾病、白天疲勞、注意力不集中和生活品質下降等問題密切相關,促使患者尋求便捷的治療方案。
止鼾器為輕度至中度打鼾患者提供了一種舒適且經濟有效的替代方案,可取代手術或持續性正壓呼吸器(CPAP)。大眾對睡眠健康的日益關注,以及醫療保健成本的不斷上漲,正推動著已開發市場和新興市場對這些產品的持續需求。
市場趨勢
推動該行業變革的關鍵趨勢之一是智慧、非侵入式止鼾設備的日益普及,這些設備融合了數位技術。製造商正在將藍牙連接、人工智慧監測、感測器和行動應用程式整合到產品中,以追蹤睡眠品質並針對每個人最佳化治療環境。
創新產品的推出進一步加速了其普及應用。例如,配備依從性監測技術的FDA核准設備使醫療專業人員能夠遠端監測患者的使用情況並改善治療效果。此外,遠端醫療與睡眠障礙管理的整合也為製造商創造了觸達更廣泛患者群體的新機會。
市場限制因素
儘管成長前景強勁,但消費者認知度低仍然是一大挑戰,尤其是在開發中國家。許多人認為打鼾無害,因此避免就醫。此外,對設備的舒適度、有效性和長期依從性的擔憂也阻礙了部分使用者的使用。
來自持續性正壓呼吸器(CPAP)療法和外科手術的競爭也阻礙了市場成長。 CPAP是治療中重度阻塞型睡眠呼吸中止症的第一線療法,通常包含在保險範圍內,因此醫療專業人員經常建議CPAP而非市面上其他止鼾設備。
市場區隔
依設備類型
預計到2026年,下顎前突矯正器(MAD)將引領全球市場,佔42.23%的市場。由於其臨床療效顯著、舒適易用,這些矯正器仍是習慣性打鼾和輕度至中度阻塞型睡眠呼吸中止症患者的首選治療方案。製造商持續投資於產品創新,並與牙科診所建立合作關係,以促進其更廣泛的應用。
此外,隨著患者尋求根據自身需求量身定做的治療方法,預計對舌頭固定裝置、鼻腔裝置、CPAP 裝置及配件和其他止鼾產品的需求將保持穩定。
透過分銷管道
預計到2026年,零售藥局通路將以38.90%的市佔率引領市場,主要得益於零售藥局網路的擴張和產品供應的改善。製造商與連鎖藥局之間達成的策略供應協議也進一步促進了線下通路的銷售。
同時,受消費者對電子商務、遠距醫療和宅配服務的偏好不斷增強的推動,預計線上藥局領域將在整個預測期內實現最快的成長。
預計北美將繼續保持在主導地位,2025年市場規模將達到4億美元,2026年將達到4.3億美元。光是美國一國預計在2026年就將佔4.1億美元的市場佔有率,這主要得益於睡眠呼吸中止症的高發病率、公眾意識的提高、有利的保險報銷政策以及先進的醫療保健基礎設施。
預計到 2025 年,歐洲市場規模將達到 3 億美元;在完善的醫療保健體系、強大的分銷網路以及主要市場參與企業的支持下,預計到 2026 年將達到 3.2 億美元。
預計到 2025 年,亞太地區的市場規模將達到 2.6 億美元,到 2026 年將成長到 2.8 億美元,這主要得益於睡眠障礙診斷數量的增加、醫療保健覆蓋範圍的擴大以及中國、印度和其他新興經濟體可支配收入的成長。
預計拉丁美洲市場規模將在2025年達到6,000萬美元,2026年達到7,000萬美元。同時,中東和非洲市場預計在2025年達到4,000萬美元,並在整個預測期內保持溫和成長。
近期行業趨勢包括產品發布、FDA 批准、與供應商合作以及旨在改善患者就醫途徑和擴大商業性覆蓋範圍的報銷計劃等措施。
The global anti-snoring devices market was valued at USD 1.06 billion in 2025 and is projected to grow from USD 1.14 billion in 2026 to USD 2.00 billion by 2032, registering a CAGR of 7.36% during the forecast period. North America dominated the global market with a 37.88% market share in 2025, supported by the high prevalence of sleep disorders, increasing awareness of obstructive sleep apnea (OSA), and the widespread availability of advanced anti-snoring products.
Anti-snoring devices are non-invasive solutions designed to keep the airway open during sleep by preventing airway obstruction and reducing tissue vibration. Popular products include mandibular advancement devices (MADs), tongue retaining devices (TRDs), nasal dilators, chin straps, and CPAP accessories. These products are increasingly being adopted by individuals suffering from habitual snoring and mild to moderate obstructive sleep apnea. Rising consumer preference for affordable, non-surgical treatment options and the growing availability of over-the-counter (OTC) devices continue to support market expansion worldwide.
Market Drivers
The rising prevalence of sleep disorders is one of the strongest factors driving the anti-snoring devices market. According to recent global estimates, nearly 936 million adults aged 30-69 years suffer from mild to severe obstructive sleep apnea, creating significant demand for effective treatment options. Untreated snoring and sleep apnea are associated with cardiovascular diseases, daytime fatigue, poor concentration, and reduced quality of life, encouraging patients to seek convenient therapeutic solutions.
Anti-snoring devices provide a comfortable and cost-effective alternative to surgical interventions and continuous positive airway pressure (CPAP) therapy, especially for patients with mild to moderate conditions. Increasing public awareness regarding sleep health, coupled with growing healthcare expenditure, continues to strengthen product demand across developed and emerging economies.
Market Trends
A key trend transforming the industry is the growing adoption of smart, non-invasive anti-snoring devices integrated with digital technologies. Manufacturers are incorporating Bluetooth connectivity, AI-enabled monitoring, sensors, and mobile applications that track sleep quality and personalize treatment settings.
Innovative product launches are further accelerating adoption. For example, FDA-cleared devices equipped with compliance monitoring technology are enabling healthcare providers to remotely monitor patient usage and improve treatment outcomes. The integration of telemedicine with sleep disorder management is also creating new opportunities for manufacturers to reach a wider patient base.
Market Restraints
Despite favorable growth prospects, limited consumer awareness remains a significant challenge, particularly across developing countries. Many individuals consider snoring a harmless condition and therefore avoid seeking medical treatment. In addition, concerns regarding device comfort, effectiveness, and long-term compliance continue to limit adoption among some users.
Competition from CPAP therapy and surgical procedures also restricts market growth. Since CPAP remains the preferred treatment for moderate to severe obstructive sleep apnea and is often covered by insurance, healthcare providers frequently recommend it over OTC anti-snoring devices.
Market Segmentation
By Device Type
The mandibular advancement devices (MADs) segment is expected to dominate the global market with a 42.23% market share in 2026. These devices remain the preferred treatment option for patients with habitual snoring and mild to moderate obstructive sleep apnea due to their clinical effectiveness, comfort, and ease of use. Manufacturers continue investing in product innovation and partnerships with dental clinics to increase adoption.
The tongue retaining devices, nasal devices, CPAP machines & accessories, and other anti-snoring products are also witnessing steady demand as patients seek personalized treatment options.
By Distribution Channel
The retail pharmacies segment is projected to lead the market with a 38.90% share in 2026, supported by increasing retail pharmacy networks and improved product accessibility. Strategic supply agreements between manufacturers and pharmacy chains are further strengthening sales through offline channels.
Meanwhile, the online pharmacies segment is expected to register the fastest growth throughout the forecast period due to increasing consumer preference for e-commerce, teleconsultation, and home delivery services.
North America generated USD 0.40 billion in 2025 and is expected to reach USD 0.43 billion in 2026, maintaining its leading position in the global market. The U.S. alone is projected to account for USD 0.41 billion in 2026, driven by the high prevalence of sleep apnea, greater awareness, favorable reimbursement policies, and advanced healthcare infrastructure.
Europe accounted for USD 0.30 billion in 2025 and is anticipated to reach USD 0.32 billion in 2026, supported by an established healthcare system, strong distribution networks, and the presence of major market participants.
Asia Pacific reached USD 0.26 billion in 2025 and is forecast to grow to USD 0.28 billion in 2026, driven by increasing diagnosis of sleep disorders, expanding healthcare access, and rising disposable income across China, India, and other emerging countries.
Latin America generated USD 0.06 billion in 2025 and is expected to reach USD 0.07 billion in 2026, while the Middle East & Africa market stood at USD 0.04 billion in 2025 and is projected to maintain gradual growth through the forecast period.
Competitive Landscape
The global anti-snoring devices market is moderately consolidated, with leading companies focusing on product innovation, geographic expansion, strategic collaborations, and awareness campaigns to strengthen their market position.
Major companies operating in the market include ResMed, Fisher & Paykel Healthcare Limited, SomnoMed, Glidewell, ProSomnus Sleep Technologies, PANTHERA DENTAL, BlueSleep, Apnea Sciences, Frantz Design Inc., and DynaFlex.
Recent industry developments include product launches, FDA approvals, supplier partnerships, and reimbursement-focused initiatives aimed at improving patient access and expanding commercial reach.
Conclusion
The global anti-snoring devices market is expected to witness steady growth through the forecast period, increasing from USD 1.06 billion in 2025 to USD 1.14 billion in 2026, ultimately reaching USD 2.00 billion by 2032. Rising awareness of sleep disorders, increasing prevalence of obstructive sleep apnea, technological advancements in smart anti-snoring devices, and expanding retail and online distribution channels are expected to sustain long-term market growth. Although competition from CPAP therapy and limited awareness in emerging regions remain challenges, continuous product innovation and expanding healthcare access are expected to create significant opportunities for manufacturers worldwide.
Segmentation By Device Type, Distribution Channel, and Region
By Device Type * Mandibular Advancement Devices
By Distribution Channel * Hospital Pharmacies
By Geography * North America (By Device Type, Distribution Channel, and Country)